Filing Flows › Embecta (EMBC) › Q2 FY25
Embecta (EMBC) Q2 FY25 earnings results (second quarter fiscal 2025)
10-Q filed May 9, 2025
Embecta (EMBC) reported revenue of $259M for the second quarter fiscal 2025 (Q2 FY25), -10% from a year earlier and -1% from the quarter before. Operating margin was 24.3%, net earnings $23.5M (9.1% of revenue).
Embecta, Q2 FY25: revenue $259M (-10% year over year), operating margin 24.3%, net earnings $23.5M, operating cash flow $31.8M. The chart follows the revenue to costs, profit and cash.
| Q2 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $259M | -1% | -10% |
| Gross profit | $164M | +4% | -11% |
| Operating profit | $62.9M | +119% | +60% |
| Net earnings | $23.5M | — | -19% |
| Operating cash flow | $31.8M | — | +31% |
| Free cash flow | $31.7M | — | +52% |
What changed
Revenue was $259.0M in Q2 FY25, down 10% year over year and down 1% from the previous quarter. Pen Needles was the largest line at 73% of revenue. Pen Needles lost $29.9M year over year (down 14%), 106% of the total change.
Gross margin was 63.4%, down 1.2 points from a year earlier. Operating profit was $62.9M, a 24.3% margin (up 10.6 points year over year). Operating expenses fell 31% while revenue fell 10%. Net earnings were $23.5M, down 19% year over year. The effective tax rate was 34.4%.
Operating cash flow was $31.8M (up 31% year over year), 135% of net earnings. Non-cash charges added back $9.0M of depreciation and amortization and $7.3M of share-based compensation. Working capital and other items used $8.0M. Capital expenditures of $100K left free cash flow of $31.7M.
Questions
What was Embecta's revenue in the second quarter fiscal 2025?
Embecta (EMBC) reported revenue of $259M for the second quarter fiscal 2025 (Q2 FY25), -10% from a year earlier and -1% from the quarter before.
Was Embecta profitable in the second quarter fiscal 2025?
Operating profit was $62.9M (24.3% of revenue) and net earnings $23.5M.
Source: Embecta 10-Q on SEC EDGAR.